ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

19,167Medicare Part D Prescriptions Filled, Including Refills

Rank: 112 out of 5176

$1.83M Total Retail Price of All Prescriptions

Rank: 66 out of 5176

497 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
96% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

2% of this provider’s 497 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

11% of this provider’s 497 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

3% of this provider’s 17,353 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

51% of this provider’s prescriptions were for brand-name drugs, compared to an average of 30%.

Prescription Price

$95 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

39 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
CRESTOR 902 841 1 15
ATENOLOL 896 805 2 12
NEXIUM 657 588 3 16
AMLODIPINE BESYLATE 614 602 4 2
ATELVIA 603 573 5 146
LIDODERM 420 396 6 59
GLIMEPIRIDE 400 389 7 37
BENICAR HCT 382 376 8 110
METOCLOPRAMIDE HCL 376 355 9 176
TAMSULOSIN HCL 360 325 10 20
LOSARTAN POTASSIUM 322 296 11 14
BENICAR 321 301 12 100
LOSARTAN-HYDROCHLOROTHIAZIDE 307 288 13 35
LIDOCAINE 296 270 14 179
ALLOPURINOL 296 286 14 41
METOPROLOL TARTRATE 294 276 16 6
PLAVIX 270 259 17 29
CLOPIDOGREL 269 259 18 26
METFORMIN HCL 249 207 19 7
ZOLPIDEM TARTRATE 245 213 20 17
EFFIENT 228 203 21 342
ONGLYZA 228 213 21 153
CELEBREX 214 196 23 80
PENICILLIN V POTASSIUM 209 186 24 467
ISOSORBIDE MONONITRATE ER 197 181 25 44
FINASTERIDE 177 151 26 69
CYCLOBENZAPRINE HCL 167 155 R 27 143
SPIRONOLACTONE 167 166 27 88
BYSTOLIC 157 157 29 96
TRIAMCINOLONE ACETONIDE 149 142 30 125
HYDROCORTISONE 148 132 31 265
DONEPEZIL HCL 144 144 32 28
MICARDIS 143 112 33 154
LOVAZA 141 121 34 43
AZITHROMYCIN 139 116 35 42
AZELASTINE HCL 137 120 36 267
DEXILANT 136 136 37 118
MECLIZINE HCL 133 130 38 81
MICARDIS HCT 132 131 39 180
MOMETASONE FUROATE 129 118 40 251
ALENDRONATE SODIUM 125 108 41 18
SIMVASTATIN 123 87 42 1
POTASSIUM CHLORIDE 121 111 43 34
ATORVASTATIN CALCIUM 120 107 44 9
PROAIR HFA 118 85 45 60
ACTOPLUS MET 113 88 46 268
EVISTA 112 101 47 65
ADVAIR DISKUS 111 96 48 32
LACTULOSE 109 105 49 87
LACLOTION 108 94 50 299
FLUTICASONE PROPIONATE 108 100 50 38
MEGACE ES 106 105 R 52 423
CLOTRIMAZOLE-BETAMETHASONE 105 87 53 94
MELOXICAM 105 98 53 53
FUROSEMIDE 104 98 55 8
ULORIC 103 99 56 280
DIGOXIN 101 99 57 56
NEOMYCIN-POLYMYXIN-DEXAMETH 100 95 58 512
RAPAFLO 99 84 59 362
AVODART 99 96 59 107
VOLTAREN 98 92 61 97
LEVOTHYROXINE SODIUM 94 83 62 4
PROMETHAZINE HCL 94 84 R 62 221
TRILIPIX 93 75 64 187
CIPROFLOXACIN HCL 92 77 65 84
CLOBETASOL PROPIONATE 89 77 66 130
SPIRIVA 85 70 67 54
TRIBENZOR 85 77 67 276
ACETAMINOPHEN-CODEINE 83 70 S3 69 127
DIOVAN HCT 80 80 70 39
OMEPRAZOLE 80 67 70 3
CARVEDILOL 79 79 72 24
SYNTHROID 79 64 72 33
PATANOL 78 74 74 158
TRICOR 75 65 75 148
GABAPENTIN 71 54 76 21
AGGRENOX 67 67 77 235
NAMENDA 66 66 78 47
MULTAQ 64 62 79 414
RANITIDINE HCL 61 59 80 36
BARACLUDE 59 47 81 373
JALYN 58 58 82 441
SOLARAZE 58 56 82 157
WARFARIN SODIUM 57 57 84 13
SULFAMETHOXAZOLE-TRIMETHOPRIM 56 46 85 181
DESOXIMETASONE 55 52 86 278
CARBIDOPA-LEVODOPA 54 54 87 98
CROMOLYN SODIUM 54 51 87 332
COMBIVENT 54 50 87 156
DICYCLOMINE HCL 54 47 87 224
ASTEPRO 53 49 91 378
SINGULAIR 53 47 91 62
NASONEX 52 37 93 178
LYRICA 50 43 94 133
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 25, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.